newsfilter
← Latest News
GlobeNewswire·

Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025

CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers